Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$79.4 - $116.36 $44.3 Million - $64.9 Million
-557,695 Closed
0 $0
Q1 2022

Apr 27, 2022

BUY
$86.42 - $109.81 $3.45 Million - $4.39 Million
39,969 Added 7.72%
557,695 $58.6 Million
Q4 2021

Feb 03, 2022

SELL
$98.56 - $119.91 $4.84 Million - $5.89 Million
-49,145 Reduced 8.67%
517,726 $55.8 Million
Q3 2021

Nov 05, 2021

BUY
$91.91 - $110.37 $12.7 Million - $15.3 Million
138,177 Added 32.23%
566,871 $62.1 Million
Q2 2021

Aug 05, 2021

BUY
$86.24 - $95.92 $33.3 Million - $37.1 Million
386,694 Added 920.7%
428,694 $40.1 Million
Q1 2021

May 06, 2021

BUY
$71.83 - $95.48 $876,326 - $1.16 Million
12,200 Added 40.94%
42,000 $3.87 Million
Q4 2020

Feb 05, 2021

BUY
$67.0 - $84.39 $2 Million - $2.51 Million
29,800 New
29,800 $2.18 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Todd Asset Management LLC Portfolio

Follow Todd Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Todd Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Todd Asset Management LLC with notifications on news.